ALZN short interest
Alzamend Neuro Inc · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 111,547 |
|---|---|
| Change vs prior report | -11,470 (-9.3%) |
| Change over six months | -65.8% |
| Days to cover | 1.09 (sector: 3.78) |
| Average daily volume | 101,975 |
| Rank in Healthcare | #769 of 922 by days to cover |
ALZN short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 111,547 | -9.3% | 1.09 | 101,975 |
| 2026-09-15 | 123,017 | -22.2% | 1.14 | 107,555 |
| 2026-08-31 | 158,044 | -10.5% | 1.04 | 152,042 |
| 2026-08-14 | 176,570 | -25.3% | 3.73 | 47,300 |
| 2026-07-31 | 236,376 | -28.0% | 4.79 | 49,306 |
| 2026-07-15 | 328,289 | +108.4% | 1.05 | 314,073 |
| 2026-06-30 | 157,517 | +25.6% | 1.00 | 335,814 |
| 2026-06-15 | 125,367 | -15.9% | 2.35 | 53,248 |
| 2026-05-29 | 149,007 | -25.3% | 1.62 | 91,969 |
| 2026-05-15 | 199,574 | -2.5% | 5.33 | 37,416 |
| 2026-04-30 | 204,743 | -17.6% | 3.47 | 58,998 |
| 2026-04-15 | 248,546 | -23.8% | 2.52 | 98,690 |
| 2026-03-31 | 326,187 | +32.6% | 1.00 | 393,998 |
| 2026-03-13 | 246,072 | -8.8% | 4.70 | 52,349 |
| 2026-02-27 | 269,773 | +2.4% | 3.42 | 78,928 |
| 2026-02-13 | 263,391 | +51.2% | 3.62 | 72,785 |
| 2026-01-30 | 174,243 | -2.0% | 1.41 | 123,391 |
| 2026-01-15 | 177,873 | -4.0% | 3.27 | 54,404 |
| 2025-12-31 | 185,292 | -30.0% | 2.98 | 62,248 |
| 2025-12-15 | 264,718 | +10.2% | 5.46 | 48,508 |
| 2025-11-28 | 240,174 | +22.4% | 1.53 | 156,772 |
| 2025-11-14 | 196,244 | +14.5% | 3.07 | 63,934 |
| 2025-10-31 | 171,426 | +63.7% | 1.35 | 126,573 |
| 2025-10-15 | 104,714 | -50.0% | 1.00 | 175,220 |
| 2025-09-30 | 209,633 | +52.5% | 1.19 | 175,734 |
import finzdata as yf
yf.Ticker("ALZN").short_interest # every report since 2017
yf.Client().short_interest(["ALZN"], start="2018-01-01")Healthcare short interest · ALZN price history · Who owns ALZN · All short interest